SJS Investment Consulting’s Vor Biopharma VOR Stock Holding History

SJS Investment Consulting’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.98K	Buy	+418	New	+$8.92K	﹤0.01%	1463

Other funds holding VOR

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return

NEXTBio Capital Management Menlo Park, California $234M AUM 176.49% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

SJS Investment Consulting's VOR Position: Q3 2026 in Review

SJS Investment Consulting opened a new position in Vor Biopharma (VOR) in Q3 2026: 418 shares worth $7.98K. The stake represents ﹤0.01% of the portfolio and ranks #1463 among its holdings.

98 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

SJS Investment Consulting held 418 shares of Vor Biopharma worth $7.98K as of Q3 2026.
Vor Biopharma was a new SJS Investment Consulting position in Q3 2026.
Vor Biopharma made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #1463 holding.
98 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.